In vitro to in vivo acetaminophen hepatotoxicity extrapolation using classical schemes, pharmacodynamic models and a multiscale spatial-temporal liver twin

Front Bioeng Biotechnol. 2023 Feb 2:11:1049564. doi: 10.3389/fbioe.2023.1049564. eCollection 2023.

Abstract

In vitro to in vivo extrapolation represents a critical challenge in toxicology. In this paper we explore extrapolation strategies for acetaminophen (APAP) based on mechanistic models, comparing classical (CL) homogeneous compartment pharmacodynamic (PD) models and a spatial-temporal (ST), multiscale digital twin model resolving liver microarchitecture at cellular resolution. The models integrate consensus detoxification reactions in each individual hepatocyte. We study the consequences of the two model types on the extrapolation and show in which cases these models perform better than the classical extrapolation strategy that is based either on the maximal drug concentration (Cmax) or the area under the pharmacokinetic curve (AUC) of the drug blood concentration. We find that an CL-model based on a well-mixed blood compartment is sufficient to correctly predict the in vivo toxicity from in vitro data. However, the ST-model that integrates more experimental information requires a change of at least one parameter to obtain the same prediction, indicating that spatial compartmentalization may indeed be an important factor.

Keywords: APAP; acetaminophen; digital twin; drug toxicity; in vitro to in vivo extrapolation; metabolism; modeling; multi-scale.

Grants and funding

Funding by BMBF-grants LiSyM (BMBF-FKZ: 031L0045: JD, DD), MS-DILI (FKZ 031L0074F: JD, DD, JGH), LiSyM-Cancer (031L0257D: DD), ANR projects iLite (ANR-16-RHUS-0005: DD), and IFLOW (ANR-13-TECS-0006: NB, DD), and EU project NOTOX (GC, DD) is gratefully acknowledged. AG was funded by the German Research Foundation (DFG; Projects ID 517010379 and ID 457840828). We acknowledge useful discussions with Lars Küpfer and Irene Vignon-Clementel.